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Abstract
Monosomy 18p refers to a chromosomal disorder resulting from the deletion of all or part of the
short arm of chromosome 18. The incidence is estimated to be about 1:50,000 live-born infants. In
the commonest form of the disorder, the dysmorphic syndrome is very moderate and non-specific.
The main clinical features are short stature, round face with short philtrum, palpebral ptosis and
large ears with detached pinnae. Intellectual deficiency is mild to moderate. A small subset of
patients, about 10–15 percent of cases, present with severe brain/facial malformations evocative of
holoprosencephaly spectrum disorders. In two-thirds of the cases, the 18p- syndrome is due to a
mere terminal deletion occurring de novo, in one-third the following are possible: a de novo
translocation with loss of 18p, malsegregation of a parental translocation or inversion, or a ring
chr18. Parental transmission of the 18p- syndrome has been reported. Cytogenetic analysis is
necessary to make a definite diagnosis. Recurrence risk for siblings is low in de novo deletions and
translocations, but is significant if a parental rearrangement is present. Deletion 18p can be
detected prenatally by amniocentesis or chorionic villus sampling and cytogenetic testing.
Differential diagnosis may include a wide number of syndromes with short stature and mild
intellectual deficiency. In young children, deletion 18p syndrome may be vaguely evocative of either
T u rn e r  s y n d r om e  o r  t ri so m y  2 1 .  N o  s pe c i f i c  treatment exists but speech therapy and early
educational programs may help to improve the performances of the children. Except for the
patients with severe brain malformations, the life expectancy does not seem significantly reduced.
Disease name/synonyms
Monosomy 18p, deletion 18p syndrome, 18p- syndrome,
del(18p) syndrome, partial monosomy 18p, de Grouchy
syndrome 1
Definition/diagnostic criteria
Monosomy 18p refers to a chromosomal disorder result-
ing from the absence of all or part of the short arm of chro-
mosome 18. It was reported in 1963 by the French
geneticist Jean de Grouchy [1,2] and was the first example
of a partial monosomy compatible with life. Clinical fea-
tures typically include mild to moderate mental retarda-
tion, short stature, round face with short protruding
philtrum, palpebral ptosis and large ears with detached
pinnae. Cytogenetic analysis is necessary to make a defi-
nite diagnosis.
Epidemiology
More than 150 patients have been reported worldwide
and most cases are no longer subject to publication. The
incidence of the disorder could be estimated as about
1:50,000 live-born infants. The female to male ratio is 3/2.
Clinical description
Manifestations of the syndrome vary greatly from one
patient to another [3,4] (Table 1). Pregnancy and delivery
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were mostly normal. Mean birth weight is in the low nor-
mal range.
Physical appearance
Except for a small subset of patients who present with
severe malformations pertaining to the holoprosenceph-
aly spectrum, the diagnosis may not be evident at birth. It
becomes easier at some years of age. Although the pheno-
type is not as characteristic as for other chromosomal syn-
dromes, many patients have a certain resemblance (Figure
1). Typical patients are small, with a short neck and a char-
acteristic posture: they stand with widespread legs and
leaning slightly forward. Mild microcephaly may be
present. The face is round, flat and expressionless, the
nasal bridge is flat and broad, the palpebral fissures are
horizontal, epicanthal folds, strabismus, and mostly pto-
sis of the eyelids when present are important features. Pto-
sis could be uni- or bilateral and may require surgical
correction. The mouth is wide, the philtrum is rather short
and protruding, Cupid's bow is blunted with a flat upper
lip and the lower lip is often everted. The irregularly set
teeth are of poor quality with significant caries, lateral
incisors are sometimes missing, palate may be high
arched. The chin is small and slightly receding in children,
becoming normal or even protruding in adults. The ears
are large, floppy, with detached pinnae and a hypoplastic
anthelix, and are often low-set and posteriorly rotated.
The hands are wide and short with phalanges of diminish-
ing width, dermatoglyphics are not characteristic. A short,
sometimes webbed neck, a low posterior hair line and a
broad chest with widely spaced nipples or pectus excava-
tum are frequent signs which can be evocative of Turner
syndrome.
Muscular hypotonia is very frequent. Puberty is normal in
most cases and fertility is possible.
Psychomotor delay
Mental retardation is usual. The intelligence quotient (IQ)
varies between 25 and 75, being around 50 in most cases,
although some patients have been reported with normal
or borderline mental development. Speech delay is fre-
quently present, and verbal and manual abilities are often
highly dissociated. Marked slowness in motion and action
has been noted [5,6]. Behavioral phenotypes such as
autism or schizophrenia sometimes complicate the men-
tal deficiency. Convulsive fits or electroencephalographic
(EEG) disturbances are rarely observed [7].
Holoprosencephaly-type defects
The main malformation is holoprosencephaly (HPE)
which involves the abnormal development of the fore-
brain and the midface, and is associated with a large phe-
notypic spectrum [8]. Severe malformations of the brain
associated with facial features such as cyplopia, ceboceph-
aly, premaxillary agenesis, bilateral cleft lip and palate are
present in 10–15 percent of cases with deletion 18p syn-
drome [9-11]. Milder forms include absent olfactory tracts
and bulbs, agenesis of corpus callosum, hypopituitarism
and minor facial features (hypo- or hypertelorism, flat
nasal bridge) with/without brain malformation. A single
central maxillary incisor as an abortive form of holopros-
Facial features in patients with Monosomy 18p syndrome Figure 1
Facial features in patients with Monosomy 18p syn-
drome. Flat midface, mild ptosis, large ears with detached 
pinnae and short protruding upper lip are frequent findings.
Table 1: Main clinical features observed in Monosomy 18p 
syndrome
Very frequent
mental retardation (variable severity)
speech delay
short stature
Frequent
variable features of the holoprosencephaly (HPE) spectrum
ptosis
flat nasal bridge
wide mouth with short upper lip
small mandible
excessive caries
large, protruding ears
short, webbed neck
broad trunk
pectus excavatum
kyphoscoliosis
Rare
behavioral disorders
autoimmune diseases
alopecia
dystoniaOrphanet Journal of Rare Diseases 2008, 3:4 http://www.ojrd.com/content/3/1/4
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encephaly has been repeatedly observed in 18p- syn-
drome [12].
Other malformations
Various skeletal deformities such as scoliosis and/or
kyphosis, coxa vara, dislocation of the hip and feet
deformities have been reported. In males, genital hypo-
plasia with small penis and cryptorchidism is occasionally
observed. Cardiac malformations appeared to be rela-
tively uncommon, observed in about 10 percent of
patients, with situs abnormalities in some cases [13]. Var-
ious other malformations have been rarely or occasionally
reported, often for deletion 18p secondary to an unbal-
anced translocation with a concomitant partial trisomy.
Other abnormalities
In those patients with short stature, growth hormone
(GH) deficiency is frequently found and may justify GH
treatment [14]. Absence or reduction of serum immu-
noglobulin A (IgA) may be present [15]. Thyroiditis lead-
ing to insufficiency or thyrotoxicosis [16], juvenile
diabetes and other auto-immune disorders have been
reported.
Hypotrichosis simplex, total baldness or alopecia areata
have been observed [9,17], as well as other rare cutaneous
disorders such as keratosis pilaris and ulerythema ophry-
ogenes [18,19]. Dystonia, a movement disorder, may
appear in young adulthood [20,21].
Genotype-phenotype correlations
Correlation between the breakpoints and the mental
development of seven subjects suggests a critical region
between p11.1 and p11.21, since three patients with a
deletion distal to this point have normal or borderline
mental development [6]. Mapping phenotypical traits
have been also attempted from a small number of
patients. Round face was tentatively mapped to the distal
1.6 Mb of chr 18 short arm, post-natal growth retardation
and seizures to the distal 8 Mb, and ptosis and short neck
to the proximal half of 18p [22]. Further studies are
needed to confirm these results [23].
Aetiology
Deletion 18p syndrome is due to the absence of all or part
of the short arm of one chromosome 18. Parental karyo-
types must be studied to determine if either is a balanced
translocation carrier or has the unbalanced 18p- deletion.
Most cases (about 2/3) are de novo deletions. The short
arm of chromosome 18 is about 16 Mb in size [24]. It is
divided in three subbands: p11.1 adjacent to the centro-
mere, p11.2 subdivided in p11.21, p11.22 and p11.23,
and p11.3 subdivided in p11.31 and p11.32 [25]. A pref-
erential breakpoint cluster at 18p11.1 has been suggested
after study of 25 non-mosaic patients with de novo dele-
tion of 18p and an apparent breakpoint cluster in the peri-
centromeric region on 18p with only 7/25 subjects with
breakpoint outside [26]. In this study, maternal and pater-
nal origin seemed to be equally common. No example of
interstitial deletion has been reported to date.
Among other reported cases, many result from an unbal-
anced whole arm translocation occuring usually between
the long arm of an acrocentric chromosome and the long
arm of chr 18 and resulting in a karyotype with 45 chro-
mosomes [27]. Other deletions 18p are the consequence
of malsegregation of a balanced parental translocation
with a variable breakpoint on 18p and are accompanied
by a partial trisomy for another chromosome. Some cryp-
tic subtelomeric deletions or translocations have been evi-
denced using subtelomeric screening [28,29].
Mosaicism or association with another aneuploidy are
sometimes observed.
Familial transmission of 18p- from one of the parent to
the child has been reported in at least six cases, most of
them with a maternal transmission [9,30,31]. Deletion
18p may be in a homogeneous or a mosaic state in the
parent, and intrafamilial clinical variability may be
present.
Deletion of 18p appears sometimes as part of a ring 18
chromosome [32] or after recombination in a pericentric
inversion leading to a 18p monosomy associated to a 18q
trisomy [33].
Relevant genes and loci
A critical region for holoprosencephaly, HPE4, has been
defined on a molecular level to the most distal segment of
18p [11]. Mutations in the TGIF gene located on 18p11.3
have been shown to cause holoprosencephaly [34].
Hemizygosity of HPE4 does not automatically confer the
phenotype of HPE, since only 10–15 percent of patients
have features consistent with HPE, confirming that multi-
ple genetic and environmental factors intervene in HPE
spectrum phenotypes. This low concordance is much
lower than those seen with other HPE loci.
An autosomal form of hereditary hypotrichosis simplex
and a susceptibility locus for alopecia areata were identi-
fied on 18p [35,36]. DYT7, one of the loci for dystonia is
known to be located on 18p [37].
Linkage studies have implicated the 18p11.2 region in
susceptibility to bipolar disorders and schizophrenia with
a parent-of-origin effect. The GNAL gene is an attractive
candidate gene [38,39].Orphanet Journal of Rare Diseases 2008, 3:4 http://www.ojrd.com/content/3/1/4
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For all these disorders, the deletion 18p could unmask a
recessive defect in the undeleted homologous chromo-
some or could lead to a loss of function of an autosomal
dominant gene with low penetrance and/or variable
expressivity.
Diagnostic methods
It is not possible to base the diagnosis of deletion 18p syn-
drome merely on the phenotype and cytogenetic analysis
is necessary to make a definite diagnosis. Diagnosis is usu-
ally done by karyotype analysis from peripheral blood. It
is also possible in prenatal period from amniocytes or tro-
phoblast cells. Systematic subtelomeric screening in men-
tally retarded patients had revealed only a low frequency
of cryptic deletions or translocations involving 18pter
[40]. However, specific subtelomeric FISH may be useful
to confirm the diagnosis and may help to characterise par-
tial deletions or cryptic translocations.
Differential diagnosis
Differential diagnosis may include a wide number of syn-
dromes presenting with short stature and mild mental
retardation. In young children, deletion 18p may be
vaguely evocative of either Turner syndrome or trisomy
21. In all cases, cytogenetic analysis allows the right diag-
nosis.
Genetic counselling
For those cases that arise de novo, the recurrence risk for
siblings is not significantly increased above that of the
general population. However, prenatal diagnosis may be
counselled because cryptic mosaicism may be present in
one of the parent.
The recurrence risk is significant if a structural rearrange-
ment is present in one of the parent. The most frequently
observed parental rearrangement is balanced transloca-
tion, followed by pericentric inversion. In those cases,
recurrence risk depends on the type of rearrangement in
which chromosomes are involved and on the size of the
rearranged segments. For some rearrangements, there is a
high risk of either a monosomy or a trisomy for 18p.
If one of the parent is carrier of a 18p deletion, the risk of
recurrence for siblings may be as high as 50 percent if the
18p deletion is present in a homogeneous state in the par-
ent, or lower if the 18p deletion is present in a mosaic
state.
Antenatal diagnosis
Deletion 18p can be detected prenatally by amniocentesis
or chorionic villus sampling and cytogenetic testing
including FISH. This could be done when a parent is het-
erozygous for a balanced rearrangement involving 18p or
carrier of a 18p deletion, following detection of a holo-
prosencephaly-type defect at sonography, or after the
birth of a first affected child. Deletion 18p is rarely
observed in first-trimester abortions suggesting that this
imbalance is not selected against.
Management including treatment
As for other chromosomal disorders, no specific treatment
exists for deletion 18p syndrome, but early rehabilitative
and educational interventions are recommended, mainly
speech therapy, since the majority of patients have major
speech problems and difficulties with speech articulation.
Physical therapy for hypotonia should be advised.
Prognosis
The prognosis is poor for those patients with severe brain
malformations; most often they die in the newborn
period. Survival does not seem to be reduced in patients
with the commonest form of deletion 18p syndrome, in
absence of severe malformations [41]. Developmental
delay is the main concern. As some children may have
average abilities in selected area, comprehensive develop-
mental assessments and remedial special education pro-
gramming should be proposed before a definite prognosis
is determined [42].
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